Arcadia Biosciences (RKDA) Scheduled to Post Earnings on Thursday

Arcadia Biosciences (NASDAQ:RKDA) is scheduled to be issuing its quarterly earnings data after the market closes on Thursday, May 9th. Analysts expect the company to announce earnings of ($2.52) per share for the quarter. Individual that are interested in registering for the company’s earnings conference call can do so using this link.

Arcadia Biosciences (NASDAQ:RKDA) last posted its earnings results on Thursday, March 28th. The basic materials company reported ($2.48) EPS for the quarter, beating the consensus estimate of ($2.68) by $0.20. Arcadia Biosciences had a negative return on equity of 81.56% and a negative net margin of 246.80%. The firm had revenue of $1.17 million during the quarter, compared to the consensus estimate of $1.80 million.

Arcadia Biosciences Price Performance

Shares of Arcadia Biosciences stock opened at $2.05 on Thursday. The stock has a market cap of $2.79 million, a price-to-earnings ratio of -0.15 and a beta of 0.60. Arcadia Biosciences has a twelve month low of $1.85 and a twelve month high of $7.30. The company’s fifty day moving average is $2.33 and its 200 day moving average is $2.71.

Wall Street Analyst Weigh In

Several research analysts have issued reports on RKDA shares. StockNews.com assumed coverage on shares of Arcadia Biosciences in a report on Monday. They set a “sell” rating for the company. HC Wainwright reaffirmed a “buy” rating and set a $10.00 price target on shares of Arcadia Biosciences in a research report on Friday, April 5th.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.